-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On August 2, Anke Biological issued an announcement stating that it had recently received the "Human Growth Hormone Injection" "Drug Supplementary Application Approval Notice" issued by the State Food and Drug Administration.
This product is based on the two specifications of the original market.
Two new specifications have been approved by the National Food and Drug Administration: 6IU/2mg/0.
6ml/bottle and 8IU/2.
66mg/0.
8ml/bottle
.
So far, a total of 4 specifications of its human growth hormone injection have been approved for marketing
The therapeutic biological product "Human Growth Hormone Injection" independently developed by Anke Biological was approved by the National Food and Drug Administration in June 2019 (Specifications: 4IU/1.
33mg/1ml/bottle, 10IU/3.
33mg/1ml/bottle )
.
A total of 6 indications have been approved: 1.